Shares in Wave Life Sciences rose by 74% after it reported clinical data with a pioneering new RNA-editing therapy for alpha-1 antitrypsin deficiency (AATD). Wave claims this is the first clinical ...

Armed with new proof-of-concept data showing that its in vivo base-editing therapy BEAM-302 can correct the gene mutation in alpha-1 antitrypsin deficiency (AATD), Beam Therapeutics is seeking to ...

Baker University has disclosed a data breach after attackers gained access to its network one year ago and stole the personal, health, and financial information of over 53,000 individuals. Nissan ...

Explainer: Why is Myanmar's junta holding an election during a civil war? Myanmar's military-led administration will hold a multi-phased general election starting on Sunday, even as a civil war rages ...

Newsrooms everywhere are grappling with the opportunities and risks of using generative AI tools. The Poynter Institute aims to support journalists in using these tools ethically and responsibly, in ...